Table 4.
Markers and prognostic score systems.
| Variables | Entire Group (n = 106) |
Hydroxychloroquine (n = 33) |
Ivermectin (n = 36) |
Placebo (n = 37) |
p |
|---|---|---|---|---|---|
| N/L Index ≥ 3, n (%) | 89 (77.7) | 30 (90.9) | 31 (86.1) | 28 (77.7) | 0.34 |
| SOFA, m (S) | 3.3 (1.6) | 3.1 (1.5) | 2.9 (1.5) | 3.8 (1.7) | 0.05 |
| SOFA < 2, n (%) | 7 (6.6) | 2 (6.1) | 4 (11.1) | 1(2.7) | 0.33 |
| 2–3, n (%) | 61 (57.6) | 21 (63.6) | 22 (61.1) | 18 (48.6) | 0.38 |
| ≥4, n (%) | 38 (35.8) | 10 (30.3) | 10 (27.7) | 18 (48.6) | 0.14 |
| APACHE II, m (±S) | 11.2 (4) | 11.1 (3.8) | 10.6 (3.7) | 11.9 (4.4) | 0.38 |
| 8–15, n (%) | 67 (63.2) | 22 (66.6) | 23 (63.8) | 22 (59.4) | 0.14 |
| >15, n (%) | 23 (21.2) | 7 (21.2) | 5 (13.8) | 11 (21.7) | 0.25 |
| CURB65, m (±S) | 1.08 (1.03) | 0.9 (0.9) | 1.1 (1) | 1.1 (1.1) | 0.77 |
| ≥2, n (%) | 37 (34.9) | 11 (33.3) | 14 (38.8) | 12 (32.4) | 0.82 |
N/L: Neutrophil/Lymphocyte, SOFA: Sequential Organ Failure Assessment Score, APACHE: Acute Physiology And Chronic Health Evaluation II, CURB65: confusion, uremia, respiratory rate, BP, age ≥ 65 years.